Inactive Instrument

DigiPath, Inc. Share Price Other OTC

Equities

DIGP

US2538252022

Fishing & Farming

Sales 2022 27L 23Cr Sales 2023 - Capitalization 12.89L 11Cr
Net income 2022 -20L -17Cr Net income 2023 - 0 EV / Sales 2022 1.21 x
Net Debt 2022 27.39L 23Cr Net Debt 2023 20.19L 17Cr EV / Sales 2023 -
P/E ratio 2022
-0.23 x
P/E ratio 2023
5.03 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 83.22%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 76 01/21/01
Director/Board Member 68 25/19/25
Members of the board TitleAgeSince
Chief Executive Officer 76 01/21/01
Director/Board Member 68 25/19/25
More insiders
Hypha Labs, Inc., formerly Digipath, Inc., has developed technology that cultivates the mycelium root structures of psilocybin mushrooms and other functional mushroom's mycelium into a natural product. This product has an exact, consistent potency containing all the natural compounds found in these fungi. Typically, it takes six-eight weeks to fully grow mushrooms, and using its technology, the production of the active ingredient is only seven-10 days. This natural product solves the dosing issue created by having to use whole mushrooms. The product is tasteless and gentler on the stomach and can be used sublingually for fast-acting results. The product allows the consumer to produce measurable active ingredients at home for mental and physical benefits. It provides Psilocybin Mushrooms, Button Mushrooms, Shiitake Mushrooms, Maitake Mushrooms, Reishi Mushrooms, Lion's Mane Mushrooms, Oyster Mushrooms, Oyster Mushrooms and Crimini Mushrooms.
More about the company